Friday, 4 September 2026
PERSPECTA
News from every angle
All
Stream
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Sanofi’s venglustat granted U.S. breakthrough therapy status for type 3 Gaucher disease
18 Mar, 06:12 — 18 Mar, 06:12
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
seeking-alpha
Mixed
170d ago
Sanofi’s venglustat granted U.S. breakthrough therapy status for type 3 Gaucher disease
Read full article →
Something wrong with this story? Report an issue
Related Stories
Salmonella Outbreak Linked to Pumpkin Seeds Infects Over 80 in France
2h ago
European Countries Report Rising West Nile Virus Cases and Deaths
4h ago
Patient Survives Nine Months After Receiving Pig Kidney Transplant
6h ago
Pediatricians Issue Health Guidelines Ahead of New School Year
9h ago
Friday, 4 September 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
